序号 |
标题 |
次数 |
作者 |
发布时间 |
74251 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH 叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
85 |
zyl |
2024-12-19 |
74252 |
Alkyne-Val-Cit-PAB-OH,ADC定制 |
127 |
wyh |
2024-12-19 |
74253 |
CAS 2395887-69-9:Mal-PEG2-Val-Cit-PAB-PNP |
80 |
WYQ |
2024-12-19 |
74254 |
CAS 1438853-35-0:Mal-PEG3-Val-Cit-PAB-PNP |
65 |
WYQ |
2024-12-19 |
74255 |
N-(Methyltetrazine-PEG4)-amido-PEG8-3,4-dithiophenolmaleimide |
98 |
zyl |
2024-12-19 |
74256 |
MC-beta-Ala-alpha-GlcA-MMAE,ADC定制 |
108 |
wyh |
2024-12-19 |
74257 |
Mal-PEG2-Val-Cit-PAB-OH(CAS: 2055041-38-6) |
70 |
WYQ |
2024-12-19 |
74258 |
cas:2100306-78-1,t-Butyl 3-(hydroxypropoxyl)-propanoate |
86 |
zyl |
2024-12-19 |
74259 |
NHS ester-PEG4-VC-PAB-Daunorubicin,ADC定制 |
70 |
wyh |
2024-12-19 |
74260 |
Mal-PEG3-Val-Cit-PAB-OH(CAS: 2727965-49-1) |
101 |
WYQ |
2024-12-19 |
74261 |
cas:1539292-60-8,tert-butyl 3-(4-(2-cyanoethynyl)phenylcarbamoyl)propylcarbamate |
63 |
zyl |
2024-12-19 |
74262 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
66 |
wyh |
2024-12-19 |
74263 |
cas:34450-18-5,Alkynyl Stearic Acid,17-十八炔酸 |
114 |
zyl |
2024-12-19 |
74264 |
Mal-PEG4-Val-Cit-PAB-OH(CAS: 2055041-39-7) |
111 |
WYQ |
2024-12-19 |
74265 |
1281816-04-3,Lys-Nε-MCC-DM1,ADC定制 |
71 |
wyh |
2024-12-19 |
74266 |
cas:120550-35-8,Biotin-PFP ester,五氟苯酚生物素酯 |
211 |
zyl |
2024-12-19 |
74267 |
MTS-ADO3A 三酸DOTA衍生物 |
98 |
h |
2024-12-19 |
74268 |
NHS-PEG2-NH-Xanomeline,ADC定制 |
83 |
wyh |
2024-12-19 |
74269 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
118 |
h |
2024-12-19 |
74270 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
76 |
h |
2024-12-19 |
74271 |
cas:2123482-78-8,TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
65 |
zyl |
2024-12-19 |
74272 |
GG-Tesirine,ADC定制 |
108 |
wyh |
2024-12-19 |
74273 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
147 |
h |
2024-12-19 |
74274 |
MC-GGFG-Exatecan,ADC定制 |
133 |
wyh |
2024-12-19 |
74275 |
亲和素-AMF-DOTA(Nd) |
95 |
h |
2024-12-19 |
74276 |
DOTA偶联人血清白蛋白微球 DOTA-HSAM |
123 |
h |
2024-12-19 |
74277 |
MC-VA-PBD,MC-Val-Ala-PBD,ADC定制 |
190 |
wyh |
2024-12-19 |
74278 |
cas:2241685-22-1,DADPS Biotin Alykne |
90 |
zyl |
2024-12-19 |
74279 |
MC-vc-PAB-C6-Alpha-Amanitin,ADC定制 |
68 |
wyh |
2024-12-19 |
74280 |
MPB-MMAF,ADC定制 |
123 |
wyh |
2024-12-19 |
74281 |
DOTA–Bipy–RuII配位共轭物 |
135 |
h |
2024-12-19 |
74282 |
cas:1007215-91-9,1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid |
107 |
zyl |
2024-12-19 |
74283 |
DOTA-cT84.66 DOTA偶联单克隆抗体cT84.66 |
82 |
h |
2024-12-19 |
74284 |
DOTA-Ahx-(D-Lys(6)-GnRH1)金属螯合剂DOTA偶联氨基己酸缀合D-赖氨酸 |
90 |
h |
2024-12-19 |
74285 |
DOTA-LRB 2-(6-(二乙基氨基)-3-(二乙基亚胺基)-3H-呫吨-9-基)-5-(N-(2-(2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基 |
89 |
h |
2024-12-19 |
74286 |
DOTA-Y3-TATE DOTA偶联激动剂Y3-TATE |
80 |
h |
2024-12-19 |
74287 |
DOTA-2-脱氧-D-氨基葡萄糖 DOTA-DG |
129 |
h |
2024-12-19 |
74288 |
DOTA-c(RGDfK)DOTA偶联环肽 |
87 |
h |
2024-12-19 |
74289 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
106 |
h |
2024-12-19 |
74290 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
89 |
h |
2024-12-19 |
74291 |
低分子量CLT1肽靶向Gd(III)螯合物CLT1-dL-(Gd-DOTA) |
149 |
h |
2024-12-19 |
74292 |
DOTA-1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺脂质 |
144 |
h |
2024-12-19 |
74293 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA17,19) |
102 |
h |
2024-12-19 |
74294 |
cas:1061569-06-9,4-formyl-N-(2-(2-hydroxyethoxy)ethyl)benzamide ADC抗体偶联药物 |
78 |
zyl |
2024-12-19 |
74295 |
DBCO-PEG4-VA-PBD,2241644-09-5,ADC定制 |
74 |
wyh |
2024-12-19 |